AKT: A Potential Target for Thyroid Cancer Therapy
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
4
Page:
181-185
Author(s):
Faiza Kada, Motoyasu Saji and Matthew D. Ringel
Molecular Elements of Apoptosis-Regulating Pathways in Follicular Thyroid Cells: Mining for Novel Therapeutic Targets in the Treatment of Thyroid Carcinoma
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
4
Page:
187-198
Author(s):
N. J. Sarlis and L. Gourgiotis
Targeting the ERK Pathway: Novel Therapeutics for Thyroid Cancer
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
4
Page:
199-220
Author(s):
Sandra F. Williams and Robert C. Smallridge
The PAX8 / PPARγ Fusion Oncogene as a Potential Therapeutic Target in Follicular Thyroid Carcinoma
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
4
Page:
221-234
Author(s):
Bryan McIver, Stefan K.G. Grebe and Norman L. Eberhardt
Viral Mediated Gene Therapy for the Management of Metastatic Thyroid Carcinoma
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
4
Page:
235-244
Author(s):
Leslie J. DeGroot and Rusheng Zhang
Telomerase as Drug and Drug Target for the Treatment of Thyroid Cancer
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
4
Page:
253-256
Author(s):
M. A. Zeiger and A. K. Meeker
A Review of Depsipeptide and Other Histone Deacetylase Inhibitors in Clinical Trials
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2289-2298
Author(s):
Richard Piekarz and Susan Bates
An Expanding Appreciation of the Role Chemokine Receptors Play in Cancer Progression
Journal:
Current Pharmaceutical Design
Volume:
10
Page:
2377-2389
Author(s):
O.M. Zack Howard and Carole L. Galligan
Signaling Pathways Responsible for Cancer Cell Invasion as Targets for Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
327-336
Author(s):
Daniel Sliva
The Akt Pathway: Molecular Targets for Anti-Cancer Drug Development
Journal:
Current Cancer Drug Targets
Volume:
4
Page:
235-256
Author(s):
Constantine S. Mitsiades, Nicholas Mitsiades and Michael Koutsilieris